Unlock instant, AI-driven research and patent intelligence for your innovation.
Novel benzimidazole compound and pharmaceutical use of same
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound and pharmaceutical technology, applied in the field of new benzimidazole compounds and their medical uses, can solve the problems of no disclosure and the like
Active Publication Date: 2018-04-17
SUMITOMO DAINIPPON PHARMA CO LTD
View PDF13 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0613] Example 1: Preparation of 1-[6-(4-fluorophenoxy)-1H-benzimidazol-1-yl]-2-methylpropan-2-alcohol (compound 1)
[0614]
[0615] Step (i): Preparation of 1-[(5-fluoro-2-nitrophenyl)amino]-2-methylpropan-2-ol (Compound 62)
[0616] A mixture of compound 61 (1.59 g), 1-amino-2-methylpropan-2-ol (0.98 g), diisopropylethylamine (5.22 mL) and DMF (50 mL) was stirred at 60 °C for 2 hours . A mixture of water and ethyl acetate / hexane (=1 / 1) was added to the reaction mixture, and the target product was extracted in the organic layer. The organic layer was dried over anhydroussodiumsulfate, and then concentrated under reduced pressure to obtain Compound 62 as a crude product.
[0617] Step (ii): Preparation of 1-[(5-(4-fluorophenoxy)-2-nitrophenyl]amino)-2-methylpropan-2-ol (compound 63)
[0618] A mixture of the crude product of compound 62 prepared in step (i), 4-fluorophenol (1.68 g), cesium carbonate (6.52 g) and NMP (25 mL) was stirred at 100 °C for 2 hours. ...
Embodiment 2
[0625] Example 2: Preparation of 6-(4-fluorophenoxy)-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole (compound 2)
[0626]
[0627] Compound 2 (0.26 g) was prepared according to the method of Example 1 by using the starting material (tetrahydrofuran-2-yl)methanol (0.607 g) instead of 1-amino-2-methylpropan-2-ol.
[0628] 1 H-NMR (DMSO-d6) δ: 1.49 (1H, m), 1.75 (2H, m), 1.94 (1H, m), 3.63 (2H, m), 4.07-4.34 (3H, m), 6.87-6.90 (1H, m), 6.97-7.02 (2H, m), 7.19 (2H, m), 7.35 (1H, m), 7.62 (1H, m), 8.14 (1H, s).
Embodiment 3
[0629] Example 3: Preparation of 6-(4-fluorophenoxy)-1-[2-(prop-2-yloxy)ethyl]-1H-benzimidazole (compound3)
[0630]
[0631] A mixture of compound 65 (0.050 g), sodiumhydride (0.011 g) and DMF (1.0 mL), prepared according to Example 1 using appropriate starting materials, was stirred at 0 °C for 30 minutes. To the reaction solution was added 2-bromopropane (0.045 g) and the mixture was further stirred at room temperature for 2 hours. To the reaction mixture were added saturated aqueous ammoniumchloride and ethyl acetate, and the target product was extracted in the organic layer. The organic layer was dried over anhydroussodiumsulfate and concentrated under reduced pressure, and then the residue was purified by silica gelcolumn chromatography (eluent: chloroform / methanol = 99 / 1) to obtain Compound 3 (9 mg).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
Extended width
aaaaa
aaaaa
Login to View More
Abstract
To provide a therapeutic agent for diseases associated with Nav 1.7, specifically diseases such as neuropathic pain, nociceptive pain, inflammatory pain, small fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, urination disorders and multiple sclerosis. Provided is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, each of R1a,R1b, R1c and R1d represents a hydrogen atom, a halogen atom, a cyano group, a C1-4 alkyl group, a C1-4 alkoxy group or the like, provided that at least one of the R1a, R1b, R1c and R1d moieties represents a C6-10 aryl group, a C6-10 aryloxy group or the like; each of R2 and R3 represents a hydrogen atom, a C1-6 alkyl group, a C3-10 cycloalkyl group or the like; R4 represents a hydrogen atom, a C1-6 alkyl group, a C3-7 cycloalkyl group or the like; m represents 1, 2 or 3; L represents a CR7R8 group; and each of R7 and R8 represents a hydrogen atom, a hydroxyl group, a C1-4 alkyl group, a C1-4 alkoxy group or the like.)
Description
technical field [0001] The present invention may relate to a medicament for treating or preventing diseases involving Na channels, especially SCN9A (Nav 1.7), comprising a novel compound having a benzimidazole skeleton or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, it relates to a medicine for treating or preventing diseases such as neuropathic pain, nociceptive pain, inflammatory pain, small fiber neuropathy, erythromelalgia, paroxysmal excruciating pain, dysuria and multiple sclerosisdrug. Background technique [0002] There are 9 known pore-forming α subunits of voltage-dependent Na channels. Recently, it has been shown that this subunit, Nav 1.7 in particular, is broadly involved in the signaling of acute and chronic pain. [0003] SCN9A (Nav 1.7) is a tetrodotoxin (TTX)-sensitive Na channel located in peripheral sensory or sympathetic nerves, which is also known as NENA or PN1. Physiologically, Nav 1.7 channels function to amp...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.